August 30th marked the start of an exciting new era in perso...
Read More A Huge Step Forward for Immunotherapy: FIRST ever FDA approved CAR-T cell therapy

August 30th marked the start of an exciting new era in perso... by Behind The Bench Staff / 09.20.2017
Read More A Huge Step Forward for Immunotherapy: FIRST ever FDA approved CAR-T cell therapy
By Greg Kaduchak, PhD What is “Event Rate”? In flow cyto... by Greg Kaduchak, PhD / 06.08.2017
Read More What are Event Rates and Should You Always Trust the “Maximum Event Rate” of your Flow Cytometer?
Tucked within an exhibit in San Diego’s Reuben H. Fleet Sc... by Grace Yco / 03.30.2017
Read More Straight From The Scientist: Jon Chesnut on CRISPR versus TALEN
What’s phosphorylation? In a simple sense, phosphorylation... by Grace Yco / 03.21.2017
Read More Light Up Phosphorylation Studies with ABfinity™ Antibodies
Dr. Andrew Filby, Ph.D. Flow Cytometry Core Facility Directo... by Suzanne Buck, PhD / 12.27.2016
Read More Studying Cell Proliferation Using CFSE? Get Advice From an Expert
Research antibodies are critical for innovation and discover... by Mathias Uhlén, PhD / 12.12.2016
Read More Validation of Antibody Specificity: Recommendations from the IWGAV and the Path Forward
Editor’s note: Antibodies are the proverbial researc... by Grace Yco / 09.07.2016
Read More Meet The Scientist Behind Fluorescent Antibody Drug Conjugation Technology
Editor’s note: research antibodies are critical for i... by Mathias Uhlén, PhD / 08.31.2016
Read More The Path to Antibody Specificity Confirmation
Pulsation in Peristaltic Pumps vs Non-Peristaltic Pumps Firs... by Greg Kaduchak, PhD / 08.17.2016
Read More Flow Cytometer Fluidics and Why They Are Not All the Same
Editor’s note: Antibodies are generally considered ... by Behind The Bench Staff / 07.19.2016
Read More ABfinity Recombinant Antibodies: The Evolution of Antibody Technology